Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Risk Factors for Suicidal Ideation in Patients Feeling Severely Affected by Multiple Sclerosis.
Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis.
Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia.
Oxidative stress and antioxidants in neurological diseases: is there still hope?
Rates of Adverse Events and Multiple Sclerosis Relapses Before and After Introduction of a Purported Generic Glatiramer Acetate in mexico: Results from a Large Patient Support Program in Mexico.
Pushing the boundaries of neuromyelitis optica: Does antibody make the disease?
Assessing risks of multiple sclerosis therapies.
Impact of a 5-day expedition to machu picchu on persons with multiple sclerosis.
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta.
Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier.
Induction of heat shock protein 70 (Hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-Jun.
Do We Need Worms to Promote Immune Health?
Cerebrospinal fluid ferritin-Unspecific and unsuitable for disease monitoring.
Evaluation of the Multiple Sclerosis Walking Scale-12 (MSWS-12) in a Dutch sample: Application of item response theory.
Cross-Recognition of a Myelin Peptide by CD8+ T Cells in the CNS Is Not Sufficient to Promote Neuronal Damage.
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Neuromyelitis optica-like pathology is dependent on Type I interferon response.
The treatment of neuromyelitis optica.
Longitudinal associations between MRI and cognitive changes in very early MS.
Neurological and psychiatric disorders as a neuroglial failure.
Risk of fractures in patients with multiple sclerosis: A population-based cohort study.
Pharmacological treatments for fatigue associated with palliative care.
Identifying Symptom Co-Occurrence in Persons With Multiple Sclerosis.
Correction: optimal attenuation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an intact interleukin-11 receptor.
[Neuromyelitis optica spectrum disorders as initial presentation of Sjögren's syndrome: A case report].

Pages